Skip to content

Clinical trials

Phase 2/3 Migraine Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Phase: Phase 2/3 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20101
20121
20151
20162
20172
20181
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Allergan1
NMT Medical1
Oregon Health and Science University1
Pharmalyte Solutions LLC1
Premiere Research Institute1
The Cooper Health System1
Yale University1
Zosano Pharma Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders13
Headache3
Hyperacusis2
Nausea2
Photophobia2
Epilepsy1
Foramen Ovale, Patent1
Heart Septal Defects, Atrial1
Pain1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.